Soft Tissue Myoepithelioma of the Shoulder by Hashimoto, Kazuhiko et al.
M yoepitheliomas of the skin or soft tissue arising solely from the myoepithelium are rare [1].  
Myoepitheliomas of the soft tissue are morphologically 
and immunophenotypically comparable to their coun-
terparts of the salivary gland [2].  Most myoepithelio-
mas of the soft tissue (75%) appear on the limbs and 
limb girdles (lower > upper); the trunk,  head,  and neck 
are less often affected [2].  To the best of our knowledge,  
only 2 cases of myoepithelioma of the shoulder have 
been reported [3 , 4].  Herein,  we describe the first case 
of deep soft tissue myoepithelioma of the shoulder.
Case Presentation
A 72-year-old woman presented to a nearby hospital 
in August 2014 with a 6-month history of a progres-
sively enlarging shoulder mass.  Magnetic resonance 
imaging (MRI) performed at that hospital revealed a 
tumor mass in the muscle between the trapezius and the 
supraspinatus.  A general surgeon performed an open 
biopsy in November 2014.  Histopathological results 
indicated fibrosarcoma.  The patient was then referred to 
our hospital in January 2015.  Physical examination 
revealed a firm nodule measuring 8.3 × 6.5 cm,  with a 
surgical wound on the nodule surface.  The patient had 
no pain or tenderness,  and Tinel’s sign was negative.  
She had full range of motion in her shoulder.  A plain 
radiograph showed enhancing soft tissue shadows.  No 
calcification was observed.  The MRI performed at the 
nearby hospital in October 2014 indicated that the mass 
was situated between the trapezius and supraspinatus 
with a low signal on T1-weighted images (Fig. 1A) and a 
high signal on T2-weighted images (Fig. 1B).  
Gadolinium (Gd)-enhanced T1-weighted MRI per-
formed at our hospital in January 2015 revealed no 
contrast effect at the center of the tumor (Fig. 1C).  
Although the tumor was close to the scapula,  
Gd-enhanced T1-weighted MRI findings did not sug-
gest that the tumor had infiltrated the scapula (Fig. 1D).  
18F-fluorodeoxyglucose-positron emission tomography 
(18FDG-PET) imaging showed an accumulation of 
18F-FDG in the mass,  with a maximum standardized 
uptake value (SUVmax) of 6.61 (Fig. 1E , F).  On reviewing 
the pathological specimens resected at the nearby hos-
pital,  we detected spindle-shaped cells arranged in an 
interlacing fascicular pattern.  We also noted that the 
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nucleus was slightly swollen,  and collagen fibers were 
observed.  Immunohistochemical findings were positive 
for CD99 and vimentin.  We also noted focal cytokera-
tin (CK),  AE1/AE3,  and epithelial membrane antigen 
(EMA) positivity,  however,  the specimen tested nega-
tive for CD34,  S-100,  desmin,  and α-smooth muscle 
actin (αSMA).  Based on these histological findings,  we 
diagnosed the patient with synovial sarcoma.  We 
planned and performed a wide resection of the tumor 
together with the surrounding muscles and the surface 
of the scapular spine en bloc.  The resected specimen was 
red and white in color and had a hard yet yielding con-
sistency.  Hematoxylin-eosin (H-E) staining showed 
proliferation of the tumor cells,  with round,  ovoid,  or 
spindle-shaped nuclei and clear acidophilic cytoplasm 
(Fig. 2A).  Heterogeneous nuclear staining was 
observed,  with differences in the size and shape of the 
nucleus (Fig. 2B).  Necrosis was also seen (Fig. 2C).  A 
predominantly reticular or trabecular growth pattern 
with prominent myxoid stroma,  which is typically 
found in myoepitheliomas,  was noted (Fig. 2D),  and 
mitosis was observed in 6/10 high power fields (HPFs).  
However,  there was no invasion into the adipose tissue 
or muscle.  Immunohistochemical examination showed 
positive staining focally for AE1/AE3 (Fig. 2E),  
CAM5.2 (Fig. 2F),  αSMA (Fig. 3A),  calponin (Fig. 3B),  
h-caldesmon (Fig. 3C),  desmin (Fig. 3D),  and vimentin 
(Fig. 3E).  Staining was negative for EMA,  S-100,  glial 
fibrillary acidic protein (GFAP),  CD31,  CD34,  bcl-2,  
and CD10.  Positive MIB-1 staining was observed,  with 
an index of 9.8% (Fig. 3F).  We also analyzed SYT-SSX 
gene fusion and EWSR1 gene translocation or rear-
rangement,  and the patient tested negative for both 
(Examinations No. 0SSL001100 and No. 0SSL001200).  
Based on these results,  myoepithelioma was diagnosed.  
The surgical margin was negative for malignant cells.  At 
the time of writing,  3 years postoperatively,  no evi-
dence of recurrence has been observed,  and the patient 
has full shoulder function.
The patient provided her written informed consent 
for the publication of this information.
Discussion and Conclusions
The first report on myoepithelioma of the soft tissue 
was published in 1997 [5].  Myoepitheliomas of the soft 
tissue are rare but have been increasingly characterized 
over the past decade [6].  Men and women are affected 
equally,  and approximately 20% of the incidence occurs 
in pediatric patients [7].  Myoepitheliomas are also 
known to occur over a wide age range (0.5-93 years),  
with a mean patient age of 32 years [7 , 8].  To the best of 
our knowledge,  the present patient is the oldest reported 
patient (Table 1).  Soft tissue myoepitheliomas often 
occur subcutaneously [1],  however,  their origin remains 
unclear [3 , 7].  In the present case,  it was suspected that 
the tumor may have developed between muscles.  As 
observed in the present case,  myoepitheliomas show high 
concentrations of 18FDG,  as do malignant tumors [9].  
The characteristics of myoepitheliomas include the pro-
liferation of tumor cells with round,  ovoid,  or spin-
dle-shaped nuclei and clear acidophilic cytoplasm; these 
were observed in the present case.  A previous study 
reports that myoepithelial cells express cytokeratin 
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Table 1　 Clinical and immunohistological features of primary myoepitheliomas of the shoulder and the present case













3Sasaguri et al.  1999 28 M Subcutaneous 3×2.8 Marginal
resection
2 years CAM5.2 αSMA,  
HHF35
None
4Min et al. 2005 43 F Subcutaneous 2.5×2.0×1.2 Marginal
resection





Current case 72 F Muscle 8.3×6.5 Extended
resection








M,  male; F,  female; IHC,  immunohistochemistry; SMA,  smooth muscle actin
(100%),  EMA (79%),  SMA (57%),  calponin (91%),  
desmin (17%),  S-100 protein (93%),  CK14 (57%),  
GFAP (50%),  and p63 (27%) [10].  As our patient tested 
positive for epithelioid markers such as AE1/AE3 and 
CAM5.2,  and for muscle-specific antigens such as 
αSMA,  calponin,  h-caldesmon,  and desmin,  we diag-
nosed her with myoepithelioma.  It is known that the 
spindle cell patterns of myoepitheliomas might mimic 
the histological patterns of other more common smooth 
muscle tumors,  such as leiomyomas and synovial sar-





Fig. 2　 Hematoxylin and eosin stained images A-D and immunohisto-
chemical staining images E,  F.  A,  Proliferation of tumor cells,  with round,  
ovoid,  or spindle-shaped nuclei and clear acidophilic cytoplasm; B,  
Heterogeneous nuclear staining was observed and mitosis and differences 
in nuclear size were detected; C,  Necrosis can be seen; D,  A predom-
inantly reticular or trabecular growth pattern with prominent myxoid stro-
ma ; E ,  Immunohistochemical staining for AE1/AE3 ; F ,  








Fig. 3　 Immunohistochemical staining images for A,  α-smooth 
muscle actin SMA (αSMA); B,  calponin; C,  h-caldesmon; D,  




Fig. 1　 A,  Coronal view of the tumor on T1-weighted magnetic 
resonance imaging MRI; B,  Sagittal view of the tumor on 
T2-weighted MRI; C,  Coronal view of the tumor on gadolinium 
Gd-enhanced T1-weighted MRI; D,  Sagittal view of the tumor on 
Gd-enhanced T2-weighted MRI; E Frontal and F coronal views of 
the tumor on 18F-fluorodeoxyglucose positron emission tomography 
(18FDG-PET).  A and B are images from the MRI scans recorded at 
a nearby hospital in October 2014.  C and D are images from the 
Gd-enhanced MRI scans recorded at our hospital in January 2015.
comas [7 , 10].  Almost all cases of leiomyosarcoma 
show positive immunostaining for desmin and negative 
immunostaining for vimentin [11].  In contrast,  myo-
epithelioma shows positive immunostaining for both 
desmin and vimentin.  Because cytokeratin-positive 
tumor cells are observed in synovial sarcoma [12],  this 
tumor should also be considered in the differential 
diagnosis.  Synovial sarcoma usually stains positive for 
S-100 [12],  but the present case showed negative S-100 
staining [13].  Recently,  myoepithelial carcinoma has 
come to be recognized as a malignant myoepithelial 
neoplasm of the soft tissue [8],  and should be consid-
ered in the differential diagnosis of myoepithelioma.  
Myoepithelial carcinoma often recurs or becomes met-
astatic,  unlike myoepithelioma [8 , 14],  however,  the 
histological and immunohistochemical features of these 
two entities are similar,  thus rendering it difficult to 
distinguish between them [8 , 14].  Important points of 
differentiation are that myoepithelial carcinoma,  unlike 
myoepithelioma,  is often positive for p63 and has a 
mean mitosis rate of 13/10 HPF [14].  Recent reports 
have shown that the malignant potential is determined 
by the degree of nuclear atypia [1 , 6].  A recent system-
atic review revealed that the long-term prognosis for 
myoepithelioma of the soft tissue is poor,  and local 
recurrence is associated with poorer resection margins 
(R1 , R2) [15].  The same review also reported that the 
percentage of severe atypia was above 50% in five stud-
ies,  and suggested that myoepithelioma of the soft tis-
sue itself might be a malignancy [15].  Although the 
present case was considered malignant due to the pres-
ence of nuclear atypia,  it may be better to treat myoep-
ithelioma itself as a malignancy.  Recent studies have 
reported that the detection of specific fusion transcripts 
can aid in better identifying myoepithelioma and facili-
tate an accurate differential diagnosis [16-20].  
Approximately 50% of myoepitheliomas show EWSR1 
translocations in various patterns [2 , 16 , 17].  Moreover,  
myoepithelial tumors that do not show EWSR1 rear-
rangement are often benign and superficially located 
and show ductal differentiation [2].  PLAG1 transloca-
tions have also been described in cases of myoepitheli-
oma with ductal differentiation [18].  Other fusion 
events have been identified in a small subset of myoepi-
thelial tumors involving the FUS gene [19].  A recent 
study reports that SRF-E2F1 fusion transcripts have 
been detected in EWSR-negative soft tissue myoepithe-
liomas.  [20].  We confirmed our diagnosis based on the 
overall histological features,  including the results of our 
immunohistochemical analysis,  which indicated posi-
tivity for epithelial and myogenic markers.  Although 
EWSR1 rearrangement was not observed in the present 
case,  the tumor had spread to a substantial depth and 
the pathological findings indicated nuclear atypia,  sug-
gesting malignancy.  In the World Health Organization 
(WHO) classification,  myoepithelioma is considered an 
intermediate (rarely metastasizing) tumor [2].  Although 
rare,  recurrence or metastasis can sometimes occur 
[7 , 8 , 10 , 15],  and tumors extending to a greater depth 
show a poorer prognosis compared to subcutaneous 
tumors [21].  Moreover,  as mentioned above,  a recent 
systematic review suggests that myoepithelioma itself 
should be treated as a malignant tumor [15].  Thus,  
wide resection and careful follow-up may be necessary.
In summary,  we present a case of deep soft tissue 
myoepithelioma of the shoulder,  which was initially 
treated by a non-specialist.  In cases in which myoepi-
thelioma is initially treated by a non-specialist,  prompt 
and effective intervention by a specialist will help avoid 
unnecessary loss of function.
Acknowledgements.　The authors would like to thank Professor 
Masanori Hisaoka of the Department of Pathology of the University of 
Occupational and Environmental Health for the pathological diagnosis.  We 
would also like to thank Editage (www. editage. jp) for English language 
editing.
References
 1. Elsensohn A,  Mo JH,  Maly TJ,  Lee PK and de Feraudy S:  
Myoepithelioma of soft tissue with both squamous and adipocytic 
metaplasia.  Am J Dermatopathol (2018) 40: 142-144.
 2. Fletcher CD,  Bridge JA,  Hogendoom PC and Mertens F: WHO 
Classification of Tumors of Soft Tissue and Bone,  4th Ed,  IARC 
Publications,  France (2013) pp 208.
 3. Sasaguri T,  Tanimoto A,  Arima N,  Hamada T,  Hashimoto H and 
Sasaguri Y: Myoepithelioma of soft tissue.  Pathol Int (1999) 49:  
571-576.
 4. Min KW,  Seo IS and Pitha J: Ossifying fibromyxoid tumor: modi-
fied myoepithelial cell tumor? Report of three cases with immuno-
histochemical and electron microscopic studies.  Ultrastruct Pathol 
(2005) 29: 535-548.
 5. Kilpatrick SE,  Hitchcock MG,  Kraus MD,  Calonje E and Fletcher CD:  
Mixed tumors and myoepitheliomas of soft tissue: a clinicopatho-
logic study of 19 cases with a unifying concept.  Am J Surg Pathol 
(1997) 1: 13-22.
 6. Jo VY and Fletcher CD: Myoepithelial neoplasms of soft tissue:  
an updated review of the clinicopathologic,  immunophenotypic,  
and genetic features.  Head Neck Pathol (2015) 1: 32-38.
 7. Hornick JL and Fletcher CD: Myoepithelial tumors of soft tissue: a 
clinicopathologic and immunohistochemical study of 101 cases 
with evaluation of prognostic parameters.  Am J Surg Pathol (2003) 
534 Hashimoto et al. Acta Med.  Okayama　Vol.  74,  No.  6
27: 1183-1196.
 8. Jo VY: Myoepithelial Tumors: An Update.  Surg Pathol Clin (2015) 
8: 445-466.
 9. Hamada K,  Ueda T,  Tomita Y,  Yoshikawa H and Hatazawa J:  
Myoepithelioma of soft tissue originating from the hand: 18F-FDG 
PET Features.  AJR Am J Roentgenol (2006) 186: 269-271.
10. Hornick JL and Fletcher CD: Cutaneous myoepithelioma: a clini-
copathologic and immunohistochemical study of 14 cases.  Hum 
Pathol (2004) 35: 14-24.
11. Iwata J and Fletcher CD: Immunohistochemical detection of cyto-
keratin and epithelial membrane antigen in leiomyosarcoma: a sys-
tematic study of 100 cases.  Pathol Int (2000) 50:
12. Chase DR,  Enzinger FM,  Weiss SW and Langloss JM: Keratin in 
epithelioid sarcoma.  An immunohistochemical study.  Am J Surg 
Pathol (1984) 8: 435-441.
13. Eswaran P,  Devadoss P,  Narasimhan LS and Kannan K: Synovial 
sarcoma of the heart: A case report and literature review.  J 
Cancer Res Ther (2015) 11: 659.
14. Frost MW,  Steiniche T,  Damsgaard TE and Stolle LB: Primary 
cutaneous myoepithelial carcinoma: a case report and review of 
the literature.  APMIS (2014) 122: 369-379.
15. Rastrelli M,  Del Fiore P,  Damiani GB,  Mocellin S,  Tropea S,  
Spina R,  Costa A,  Cavallin F and Rossi CR: Myoepithelioma of 
the soft tissue: A systematic review of clinical reports.  Eur J Surg 
Oncol (2019) 45: 1520-1526.
16. Antonescu CR,  Zhang L,  Chang NE,  Pawel BR,  Travis W,  Katabi N,  
Edelman M,  Rosenberg AE,  Petur Nielsen G,  Cin PD and 
Fletcher CD: EWSR1-POU5F1 fusion in soft tissue myoepithelial 
tumors.  A molecular analysis of sixty-six cases,  including soft tis-
sue,  bone,  and visceral lesions,  showing common involvement of 
the EWSR1 gene.  Genes Chromosomes Cancer (2010) 49: 1114-
1124.
17. Flucke U,  Palmedo G,  Blankenhorn N,  Slootweg PJ,  Kutzner H 
and Mentzel T: EWSR1 gene rearrangement occurs in a subset of 
cutaneous myoepithelial tumors: a study of 18 cases.  Mod Pathol 
(2011) 24: 1444-1450.
18. Antonescu CR,  Zhang L,  Shao SY,  Mosquera JM,  Weinreb I,  
Katabi N and Fletcher CD: Frequent PLAG1 gene rearrangements 
in skin and soft tissue myoepithelioma with ductal differentiation.  
Genes Chromosomes Cancer (2013) 52: 675-682.
19. Huang SC,  Chen HW,  Zhang L,  Sung YS,  Agaram NP,  Davis M,  
Edelman M,  Fletcher CD and Antonescu CR: Novel FUS-KLF17 and 
EWSR1-KLF17 fusions in myoepithelial tumors.  Genes Chromosomes 
Cancer (2015) 54: 267-275.
20. Urbini M,  Astolfi A,  Indio V,  Tarantino G,  Serravalle S,  Saponara M,  
Nannini M,  Gronchi A,  Fiore M,  Maestro R and Brenca M:  
Identification of SRF-E2F1 fusion transcript in EWSR-negative 
myoepithelioma of the soft tissue.  Oncotarget (2017) 8: 60036-
60045.
21. Yokose C,  Asai J,  Kan S,  Nomiyama T,  Takenaka H,  Konishi E,  
Goto K,  Ansai SI and Katoh N: Myoepithelial carcinoma on the 
right shoulder: Case report with published work review.  J Dermatol 
(2016) 43: 1083-1087.
December 2020 Myoepithelioma of the Shoulder 535
